Givaudan completes acquisition of Ungerer
09:54 AM | February 21, 2020 | Mark Thomas
Ungerer's business would have represented $250 million of incremental sales to Givaudan's 2019 results on a pro forma basis.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.